Notch's partner lab has received Emergency Use Authorization from the FDA to employ COVID-19 tests.* As recommended by the CDC, we use real-time reverse transcription polymerase chain reaction (RT-PCR) tests to qualitatively detect nucleic acid from SARS-CoV-2 (COVID-19). This type of testing is considered more accurate than most “rapid” tests.
Benchmarks for the accuracy PCR testing for COVID-19 have been set by the FDA and must exceed 95 percent at measurable concentrations. The accuracy of Notch’s COVID-19 testing lab exceeds 95 percent sensitivity and 98 percent specificity. The specificity of the RT-PCR is also tested regularly to ensure that newly discovered COVID-19 mutations are detected by the test.
*Please note that this is a diagnostic test, not an antibody test.